These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 15620422

  • 1. Monoaminergic neuronal development is not affected in PACAP-gene-deficient mice.
    Ogawa T, Nakamachi T, Ohtaki H, Hashimoto H, N S, Baba A, Watanabe J, Kikuyama S, Shioda S.
    Regul Pept; 2005 Mar 15; 126(1-2):103-8. PubMed ID: 15620422
    [Abstract] [Full Text] [Related]

  • 2. PACAP deficient mice display reduced carbohydrate intake and PACAP activates NPY-containing neurons in the rat hypothalamic arcuate nucleus.
    Nakata M, Kohno D, Shintani N, Nemoto Y, Hashimoto H, Baba A, Yada T.
    Neurosci Lett; 2004 Nov 11; 370(2-3):252-6. PubMed ID: 15488333
    [Abstract] [Full Text] [Related]

  • 3. Pituitary adenylate cyclase-activating polypeptide (PACAP) can act as determinant of the tyrosine hydroxylase phenotype of dopaminergic cells during retina development.
    Borba JC, Henze IP, Silveira MS, Kubrusly RC, Gardino PF, de Mello MC, Hokoç JN, de Mello FG.
    Brain Res Dev Brain Res; 2005 May 12; 156(2):193-201. PubMed ID: 16099306
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of PACAP in the pancreas failed to rescue early postnatal mortality in PACAP-null mice.
    Shintani N, Hashimoto H, Tanaka K, Kawaguchi C, Tomimoto S, Baba A.
    Regul Pept; 2004 Dec 15; 123(1-3):155-9. PubMed ID: 15518906
    [Abstract] [Full Text] [Related]

  • 5. Reduced hypothermic and hypnotic responses to ethanol in PACAP-deficient mice.
    Tanaka K, Hashimoto H, Shintani N, Yamamoto A, Baba A.
    Regul Pept; 2004 Dec 15; 123(1-3):95-8. PubMed ID: 15518898
    [Abstract] [Full Text] [Related]

  • 6. Noncompensation in peptide/receptor gene expression and distinct behavioral phenotypes in VIP- and PACAP-deficient mice.
    Girard BA, Lelievre V, Braas KM, Razinia T, Vizzard MA, Ioffe Y, El Meskini R, Ronnett GV, Waschek JA, May V.
    J Neurochem; 2006 Oct 15; 99(2):499-513. PubMed ID: 17029602
    [Abstract] [Full Text] [Related]

  • 7. Altered cerebellar development in mice lacking pituitary adenylate cyclase-activating polypeptide.
    Allais A, Burel D, Isaac ER, Gray SL, Basille M, Ravni A, Sherwood NM, Vaudry H, Gonzalez BJ.
    Eur J Neurosci; 2007 May 15; 25(9):2604-18. PubMed ID: 17561835
    [Abstract] [Full Text] [Related]

  • 8. Diverse effects of intrathecal pituitary adenylate cyclase-activating polypeptide on nociceptive transmission in mice spinal cord.
    Shimizu T, Katahira M, Sugawara H, Inoue K, Miyata A.
    Regul Pept; 2004 Dec 15; 123(1-3):117-22. PubMed ID: 15518901
    [Abstract] [Full Text] [Related]

  • 9. Present status of knowledge about the distribution and colocalization of PACAP in the forebrain.
    Köves K, Görcs TJ, Kausz M, Arimura A.
    Acta Biol Hung; 1994 Dec 15; 45(2-4):297-321. PubMed ID: 7725824
    [Abstract] [Full Text] [Related]

  • 10. Effect of pituitary adenylate cyclase-activating polypeptide 38 (PACAP38) on tissue oxygen content--treatment in central nervous system of mice.
    Ohtaki H, Dohi K, Yofu S, Nakamachi T, Kudo Y, Endo S, Aruga T, Goto N, Watanabe J, Kikuyama S, Shioda S.
    Regul Pept; 2004 Dec 15; 123(1-3):61-7. PubMed ID: 15518894
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of lipopolysaccharide on the transport of pituitary adenylate cyclase activating polypeptide across the blood-brain barrier.
    Nonaka N, Shioda S, Banks WA.
    Exp Neurol; 2005 Jan 15; 191(1):137-44. PubMed ID: 15589520
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Localization, characterization and function of pituitary adenylate cyclase-activating polypeptide during brain development.
    Watanabe J, Nakamachi T, Matsuno R, Hayashi D, Nakamura M, Kikuyama S, Nakajo S, Shioda S.
    Peptides; 2007 Sep 15; 28(9):1713-9. PubMed ID: 17719696
    [Abstract] [Full Text] [Related]

  • 15. Changes in pituitary adenylate cyclase activating polypeptide expression in urinary bladder pathways after spinal cord injury.
    Zvarova K, Dunleavy JD, Vizzard MA.
    Exp Neurol; 2005 Mar 15; 192(1):46-59. PubMed ID: 15698618
    [Abstract] [Full Text] [Related]

  • 16. Pituitary adenylate cyclase-activating polypeptide (PACAP)-like immunoreactivity in the brain of a teleost, Uranoscopus japonicus: immunohistochemical relationship between PACAP and adenohypophysial hormones.
    Matsuda K, Nagano Y, Uchiyama M, Onoue S, Takahashi A, Kawauchi H, Shioda S.
    Regul Pept; 2005 Mar 15; 126(1-2):129-36. PubMed ID: 15620426
    [Abstract] [Full Text] [Related]

  • 17. Pleiotropic functions of PACAP in the CNS: neuroprotection and neurodevelopment.
    Shioda S, Ohtaki H, Nakamachi T, Dohi K, Watanabe J, Nakajo S, Arata S, Kitamura S, Okuda H, Takenoya F, Kitamura Y.
    Ann N Y Acad Sci; 2006 Jul 15; 1070():550-60. PubMed ID: 16888224
    [Abstract] [Full Text] [Related]

  • 18. Regulation of autonomic nerve activities by central pituitary adenylate cyclase-activating polypeptide.
    Tanida M, Shintani N, Morita Y, Tsukiyama N, Hatanaka M, Hashimoto H, Sawai H, Baba A, Nagai K.
    Regul Pept; 2010 Apr 09; 161(1-3):73-80. PubMed ID: 20171991
    [Abstract] [Full Text] [Related]

  • 19. Expression of pituitary adenylate cyclase activating polypeptide and its type I receptor mRNAs in human placenta.
    Koh PO, Won CK, Noh HS, Cho GJ, Choi WS.
    J Vet Sci; 2005 Mar 09; 6(1):1-5. PubMed ID: 15785117
    [Abstract] [Full Text] [Related]

  • 20. Pituitary adenylate cyclase-activating polypeptide (PACAP) is important for embryo implantation in mice.
    Isaac ER, Sherwood NM.
    Mol Cell Endocrinol; 2008 Jan 02; 280(1-2):13-9. PubMed ID: 17945412
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.